Latest stories on ACON
Aclarion reports Nociscan validated by strong agreement with discography
The Fly61 · neutralproduct/pr
Aclarion Announces New Real-World Publication: Nociscan® Validated by Strong Agreement with Discography in Diagnosing Painful Lumbar Discs
GlobeNewswire58 · neutralproduct/pr
Aclarion reports 85% Q3 scan volume growth, $14.2M in cash
The Fly63 · neutralearnings
Aclarion Publishes CEO Shareholder Letter Highlighting Continued Scan Volume Growth and Advancing Clinical Program in Third Quarter 2026
GlobeNewswire64 · neutralproduct/pr
Aclarion Publishes CEO Shareholder Letter Highlighting Continued Scan Volume Growth and Advancing Clinical Program in Third Quarter 2026
Business Insider64 · neutralproduct/pr
Aclarion to Present at the 20th Annual LD Micro Main Event
Business Insider56 · neutralproduct/pr
Aclarion to Present at the 20th Annual LD Micro Main Event
GlobeNewswire56 · neutralproduct/pr
Aclarion broadens CLARITY trial enrollment criteria
The Fly58 · neutralproduct/pr
Aclarion Broadens CLARITY Trial Enrollment Criteria to Accelerate Enrollment
GlobeNewswire61 · neutralproduct/pr
Aclarion Broadens CLARITY Trial Enrollment Criteria to Accelerate Enrollment
Business Insider61 · neutralproduct/pr
Aclarion announces NYU Langone Health as new clinical site for CLARITY trial
The Fly59 · neutralproduct/pr
Aclarion Welcomes NYU Langone Health to CLARITY Trial Network, Now Enrolling at Eleven Sites
Business Insider59 · neutralgeneral
Aclarion Welcomes NYU Langone Health to CLARITY Trial Network, Now Enrolling at Eleven Sites
GlobeNewswire59 · neutralgeneral
Alger Concentrated Equity ETF Q2 2026 Portfolio Update
Seeking Alpha55 · neutralgeneral
Alger Concentrated Equity ETF Q2 2026 Commentary
Seeking Alpha55 · neutralgeneral
Aclarion adds University of Arizona Phoenix as tenth CLARITY trial site
The Fly58 · neutralproduct/pr
Aclarion Announces Addition of University of Arizona College of Medicine – Phoenix as CLARITY Trial Site
StockTitan58 · neutralproduct/pr
Aclarion Publishes CEO Shareholder Letter Highlighting Progress for First Half of 2026
Business Insider63 · neutralproduct/pr
Aclarion Announces Presentation of Two Abstracts Highlighting Nociscan’s Growing Role in Real-World Clinical Practice
StockTitan57 · neutralproduct/pr
Aclarion Announces Texas Spine Care Center as New CLARITY Site | ACON Stock News
StockTitan56 · neutralproduct/pr
Aclarion Rejects Echo Lake Capital’s Unsolicited Acquisition Proposal | ACON Stock News
StockTitan32 · bearishm&a
Aclarion Stockholders Approve All Proposals at 2026 Annual Meeting | ACON Stock News
StockTitan55 · neutralgeneral